NEW YORK (GenomeWeb News) - BioNanomatrix and Princeton University will use a $200,000 grant from the National Cancer Institute to develop a nanofluidics technology for cell fractionation, the company said today.
 
Under the two-year Small Technology Transfer Research grant, BioNanomatrix and Princeton’s Institute for the Science and Technology of Materials will develop a front-end sample-sorting component for the company’s BioNanomatrix whole-genome analytic platform.  
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.